Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Targeting the Genital Microbiota to Reduce Human Immunodeficiency Virus Transmission Among African, Caribbean, and other Black Women
EF 2018-19
Résumé
African, Caribbean, and other Black (ACB) women experience disproportionately high HIV risk in Ontario. A significant portion of this risk may be due to variation in the types of bacteria in the female genital tract (FGT), collectively known as the vaginal microbiome.
The types of bacteria that colonize the vagina differ between women, and the vaginal microbiome composition has been linked to reproductive health outcomes including HIV acquisition after a sexual exposure. High diversity of bacterial species in the vaginal microbiome may lead to a condition known as bacterial vaginosis (BV). Although BV is often asymptomatic, it has been linked to increased HIV susceptibility, and unfortunately is more common in ACB women. Antibiotic treatment of BV can reverse these changes in the short term, but BV usually recurs within a few months. In addition, my supervisor’s research group has found that antibiotic treatment actually increased some immune indicators of HIV risk.
The proposed research aims to test novel microbiome-focused clinical strategies, both antibiotic- and probiotic-based, to reduce HIV susceptibility among ACB women. I hypothesize that standard antibiotic treatment for BV will increase certain immune indicators of HIV susceptibility and recruit HIV target cells to the vaginal lining, but that addition of a novel probiotic will restore the vaginal microbiome to a state that is protective against HIV.
The elevated HIV risk faced by ACB women emphasizes the urgent need for better clinical strategies to reduce HIV susceptibility among this population. We hope that the results of this proposed research can inform future clinical strategies to reduce HIV susceptibility among women and the ACB community.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
406576
Name
Armstrong Eric
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Targeting the Genital Microbiota to Reduce Human Immunodeficiency Virus Transmission Among African, Caribbean, and other Black Women
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bacterial Infections; Cell Biology; Cytokines And Chemokines; Genital Microbiome; Hiv/Aids; Infectious Diseases; Mucosal Immunology; Reproductive Biology; Sexually Transmitted Infections; T Cell Responses
Abstract
African, Caribbean, and other Black (ACB) women experience disproportionately high HIV risk in Ontario. A significant portion of this risk may be due to variation in the types of bacteria in the female genital tract (FGT), collectively known as the vaginal microbiome.
The types of bacteria that colonize the vagina differ between women, and the vaginal microbiome composition has been linked to reproductive health outcomes including HIV acquisition after a sexual exposure. High diversity of bacterial species in the vaginal microbiome may lead to a condition known as bacterial vaginosis (BV). Although BV is often asymptomatic, it has been linked to increased HIV susceptibility, and unfortunately is more common in ACB women. Antibiotic treatment of BV can reverse these changes in the short term, but BV usually recurs within a few months. In addition, my supervisor’s research group has found that antibiotic treatment actually increased some immune indicators of HIV risk.
The proposed research aims to test novel microbiome-focused clinical strategies, both antibiotic- and probiotic-based, to reduce HIV susceptibility among ACB women. I hypothesize that standard antibiotic treatment for BV will increase certain immune indicators of HIV susceptibility and recruit HIV target cells to the vaginal lining, but that addition of a novel probiotic will restore the vaginal microbiome to a state that is protective against HIV.
The elevated HIV risk faced by ACB women emphasizes the urgent need for better clinical strategies to reduce HIV susceptibility among this population. We hope that the results of this proposed research can inform future clinical strategies to reduce HIV susceptibility among women and the ACB community.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Armstrong, Eric
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~